Interacting Drugs |
Pegylated interferon (peginterferon) alfa-2b and ribavirin vs Reverse Transcriptase Inhibitors (Nucleoside) |
Security Level |
 |
Mechanism |
Reverse Transcriptase Inhibitors (Nucleoside): Ribavirin may enhance the hepatotoxic effect of Reverse Transcriptase Inhibitors (Nucleoside). Lactic acidosis may occur. |
Management |
Consider therapy modification |
Pegylated interferon (peginterferon) alfa-2b and ribavirin vs Reverse Transcriptase Inhibitors (Nucleoside)
Post Review about Pegylated interferon (peginterferon) alfa-2b and ribavirin vs Reverse Transcriptase Inhibitors (Nucleoside) Click here to cancel reply.
Other Interactions of Pegylated interferon (peginterferon) alfa-2b and ribavirin
Other Interactions of Reverse Transcriptase Inhibitors (Nucleoside)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.